Pay in 4 interest-free payments of $7.34 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Mounjaro Mounjaro, developed by Eli Lilly and Company, is a once-weekly injectable that combines the effects of two hormones: GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide)
The three-receptor design creates what researchers describe as a more complete metabolic reset
Mass spectrometry (MS) confirms identity by measuring molecular weight and fragmentation
We also offer brand-name Wegovy and Zepbound when clinically appropriate, but our day-to-day experience is primarily with compounded medications
(2023, June 28)
Our team has reviewed this across hundreds of clients working with research peptides
US$ 27.15
US$ 24.04
US$ 26.85
US$ 26.71
US$ 26.02
US$ 25.31
US$ 20.45
